Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma
Clinical trial NCT00091676 · UNKNOWN
Trial details
- NCT number
- NCT00091676
- Sponsor
- Biovest International
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-01-01
- Primary completion
- 2012-12-01
- Enrollment
- 629
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.